Medirom Healthcare Financials

MRM Stock  USD 6.00  0.01  0.17%   
Based on the measurements of operating efficiency obtained from Medirom Healthcare's historical financial statements, Medirom Healthcare Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May.
With this module, you can analyze Medirom financials for your investing period. You should be able to track the changes in Medirom Healthcare individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Medirom Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medirom Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Medirom Healthcare's assets may result in an increase in income on the income statement.
The data published in Medirom Healthcare's official financial statements usually reflect Medirom Healthcare's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Medirom Healthcare. For example, before you start analyzing numbers published by Medirom accountants, it's critical to develop an understanding of what Medirom Healthcare's liquidity, profitability, and earnings quality are in the context of the Hotels, Restaurants & Leisure space in which it operates.
Please note, the presentation of Medirom Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medirom Healthcare's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Medirom Healthcare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medirom Healthcare Technologies. Please utilize our Beneish M Score to check the likelihood of Medirom Healthcare's management manipulating its earnings.

Medirom Healthcare Stock Summary

Medirom Healthcare competes with HR Block, Service International, Rollins, WW International, and Carriage Services. MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. MEDIROM Healthcare operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. It employs 171 people.
Specialization
Consumer Cyclical, Personal Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS58510H1032
CUSIP58510H103
LocationJapan
Business AddressTradepia Odaiba, Tokyo,
SectorHotels, Restaurants & Leisure
IndustryConsumer Discretionary
BenchmarkNYSE Composite
Websitemedirom.co.jp
Phone81 3 6721 7364
CurrencyUSD - US Dollar
You should never invest in Medirom Healthcare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medirom Stock, because this is throwing your money away. Analyzing the key information contained in Medirom Healthcare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Medirom Healthcare Key Financial Ratios

Generally speaking, Medirom Healthcare's financial ratios allow both analysts and investors to convert raw data from Medirom Healthcare's financial statements into concise, actionable information that can be used to evaluate the performance of Medirom Healthcare over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medirom Healthcare reports annually and quarterly.

Medirom Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Medirom Healthcare's current stock value. Our valuation model uses many indicators to compare Medirom Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medirom Healthcare competition to find correlations between indicators driving Medirom Healthcare's intrinsic value. More Info.
Medirom Healthcare Technologies is regarded fifth in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medirom Healthcare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medirom Healthcare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medirom Healthcare's earnings, one of the primary drivers of an investment's value.

Medirom Healthcare Systematic Risk

Medirom Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medirom Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Medirom Healthcare correlated with the market. If Beta is less than 0 Medirom Healthcare generally moves in the opposite direction as compared to the market. If Medirom Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medirom Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medirom Healthcare is generally in the same direction as the market. If Beta > 1 Medirom Healthcare moves generally in the same direction as, but more than the movement of the benchmark.

About Medirom Healthcare Financials

What exactly are Medirom Healthcare Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Medirom Healthcare's income statement, its balance sheet, and the statement of cash flows. Potential Medirom Healthcare investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Medirom Healthcare investors may use each financial statement separately, they are all related. The changes in Medirom Healthcare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medirom Healthcare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Medirom Healthcare Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Medirom Healthcare is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Medirom has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Medirom Healthcare's financials are consistent with your investment objective using the following steps:
  • Review Medirom Healthcare's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Medirom Healthcare's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Medirom Healthcare's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Medirom Healthcare's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Medirom Healthcare Thematic Clasifications

Medirom Healthcare Technologies is part of Personal Services investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Personal Services industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Personal ServicesView
This theme covers USA Equities from Personal Services industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas

Medirom Healthcare April 18, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Medirom Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medirom Healthcare Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medirom Healthcare Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Medirom Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medirom Healthcare's daily price indicators and compare them against related drivers.
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Medirom Stock analysis

When running Medirom Healthcare's price analysis, check to measure Medirom Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medirom Healthcare is operating at the current time. Most of Medirom Healthcare's value examination focuses on studying past and present price action to predict the probability of Medirom Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medirom Healthcare's price. Additionally, you may evaluate how the addition of Medirom Healthcare to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Medirom Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.